Tue. 12 Mar 2024, 4:27pm ET
Benzinga
Earnings, Earnings Beats, News
ClearPoint Neuro (NASDAQ:CLPT) reported quarterly losses of $(0.19) per share which beat the analyst consensus estimate of $(0.20) by 5 percent. The company reported quarterly sales of $6.810 million which beat the analyst consensus estimate of $6.533 million by 4.23 percent. This is a 31.62 percent increase over sales of $5.174 million the same period last year.